Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch... Laboratory Biomarker Analysis, Naproxen, Placebo NCT02052908 National Cancer Institute (NCI) Active, not recruiting
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer Laboratory Biomarker Analysis, Nelipepimut-S Plus GM-CSF Vaccine, Sargramostim NCT02636582 National Cancer Institute (NCI) Active, not recruiting
Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-... Denosumab, Salpingo-Oophorectomy NCT03382574 National Cancer Institute (NCI) Recruiting
Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer... Laboratory Biomarker Analysis, Pharmacological Study, Placebo, Pomegranate-Extract Pill NCT02095145 National Cancer Institute (NCI) Active, not recruiting
Preventive Human Papilomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine NCT03036930 National Cancer Institute (NCI) Recruiting
PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer... Laboratory Biomarker Analysis, Placebo, Rilimogene Galvacirepvec NCT02326805 National Cancer Institute (NCI) Active, not recruiting
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger... Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine NCT02568566 National Cancer Institute (NCI) Active, not recruiting
Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer Laboratory Biomarker Analysis, Retinoid 9cUAB30, Therapeutic Conventional Surgery NCT02876640 National Cancer Institute (NCI) Recruiting
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis Laboratory Biomarker Analysis, Placebo, Questionnaire Administration, Simvastatin NCT02968810 National Cancer Institute (NCI) Recruiting
Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis Laboratory Biomarker Analysis, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Simvastatin NCT02743364 National Cancer Institute (NCI) Active, not recruiting

Pages